As mentioned earlier, gene amplification or copy number gain is a commonly reported genomic event leading to MET overexpression and ligand-independent activation, which has been shown to confer transformative potential in various cancers including glioblastoma [84], NSCLC [85], colorectal cancer [86], and medulloblastoma [87]. The gene discussed is MET; the disease is non-small cell lung carcinoma.